What was AnaptysBio Inc’s price range in the past 12 months?
AnaptysBio Inc lowest stock price was $21.26 and its highest was $29.75 in the past 12 months.
What is AnaptysBio Inc’s market cap?
Currently, no data Available
When is AnaptysBio Inc’s upcoming earnings report date?
AnaptysBio Inc’s upcoming earnings report date is May 09, 2023 which is in 38 days.
How were AnaptysBio Inc’s earnings last quarter?
AnaptysBio Inc released its earnings results on Mar 01, 2023. The company reported -$0.93 earnings per share for the quarter, beating the consensus estimate of -$0.957 by $0.027.
How many shares outstanding does AnaptysBio Inc have?
Currently, no data Available
What happened to AnaptysBio Inc’s price movement after its last earnings report?
AnaptysBio Inc reported an EPS of -$0.93 in its last earnings report, beating expectations of -$0.957. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of AnaptysBio Inc?
Among the largest hedge funds holding AnaptysBio Inc’s share is Deerfield Management Company, LP. It holds AnaptysBio Inc’s shares valued at 36M.
The AnaptysBio Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
AnaptysBio, Inc. is a clinical stage biotechnology company, which engages in developing antibody product candidates focused on unmet medical needs in inflammation. Its pipeline includes ANB020, ANB019, and checkpoint receptor agonist antibodies. The company was founded by Andrew B. Cubitt, William J. Boyle and Nicholas B. Lydon in November 2005 and is headquartered in San Diego, CA.